Amarin Corporation plc (NASDAQ: AMRN) Q3 2020 earnings call dated Nov. 05, 2020 Corporate Participants: Elisabeth Schwartz -- Senior Director, Investor Relations John Thero -- President
Search Results for: Teva
Bausch Health Companies Inc. (BHC) Q3 2020 Earnings Call Transcript
Bausch Health Companies Inc. (NYSE: BHC) Q3 2020 earnings call dated Nov. 03, 2020 Corporate Participants: Arthur Shannon -- Senior Vice President of Investor
Eagle Pharmaceuticals Inc. (EGRX) Q3 2020 Earnings Call Transcript
Eagle Pharmaceuticals Inc. (NASDAQ: EGRX) Q3 2020 Earnings Call dated Nov. 02, 2020 Corporate Participants: Lisa M. Wilson -- Investor Relations - In-Site Communications,
Catalent Inc (CTLT) Q4 2020 Earnings Call Transcript
Catalent Inc (NYSE: CTLT) Q4 2020 Earnings Call dated Aug. 31, 2020 Corporate Participants: Paul Surdez -- Vice President, Investor Relations John
Amarin (AMRN) stock to remain within a tight range until the end of Vascepa litigation
The patent war between Amarin (NASDAQ: AMRN) and the generic companies for cardiovascular drug Vascepa continues to be a headwind for Amarin.
Deckers Outdoor Corp (NYSE: DECK) Q4 2020 Earnings Call Transcript
Deckers Outdoor Corp (DECK) Q4 2020 earnings call dated May 21, 2020 Corporate Participants: Erinn Kohler -- Vice President of Investor Relations & Corporate
Antares Pharma Inc (NASDAQ: ATRS) Q1 2020 Earnings Call Transcript
Antares Pharma Inc (ATRS) Q1 2020 earnings call dated May 05, 2020 Corporate Participants: Jack Howarth -- Vice President Corporate Affairs Robert F. Apple -- President
Corcept Therapeutics Incorporated (NASDAQ: CORT) Q1 2020 Earnings Call Transcript
Corcept Therapeutics Incorporated (CORT) Q1 2020 earnings call dated May 04, 2020 Corporate Participants: Charles Robb -- Chief Financial Officer Joseph K Belanoff -- Chief Executive
Eagle Pharmaceuticals Inc (NASDAQ: EGRX) Q1 2020 Earnings Call Transcript
Eagle Pharmaceuticals Inc (EGRX) Q1 2020 earnings call dated May. 11, 2020 Corporate Participants: Lisa Wilson -- Investor Relations Scott Tarriff -- Founder, Chief Executive Officer
Amarin Corporation plc (NASDAQ: AMRN) Q1 2020 Earnings Call Transcript
Amarin Corporation plc (AMRN) Q1 2020 earnings call dated Apr. 13, 2020 Corporate Participants: Elisabeth Schwartz -- Senior Director of Investor Relations John Thero -- President
Bausch Health Companies Inc. (NYSE: BHC) Q4 2019 Earnings Call Transcript
Bausch Health Companies Inc. (BHC) Q4 2019 earnings call dated Feb. 19, 2020 Corporate Participants: Arthur J. Shannon -- Senior Vice President and Head
Accenture PLC (NYSE: ACN) Q2 2020 Earnings Call Transcript
Accenture PLC (NYSE: ACN) Q2 2020 Earnings Conference Call Corporate Participants: Angie Park -- Managing Director & Head of Investor Relations Julie Sweet -- Chief Executive Officer
Johnson & Johnson tumbles on rating downgrade, after opioid ruling
Johnson & Johnson (NYSE: JNJ) continued the slide Wednesday after suffering a big loss in the previous trading session as investor mood
Mylan under pressure as shortage of anti-allergy injector persists
Pharmaceutical company Mylan (Nasdaq: MYL), which has been facing criticism for the short supply of its anti-allergy injector EpiPen, suffered a jolt
What the future holds for generic drug industry
The size of the generic drug market in the US is so large that about 90% of all prescription medicines sold last
What’s in store for top pharma stocks this year
The stocks of leading pharmaceutical firms shifted to growth mode this year after winding up 2018 on a low note, in line
Looming opioid epidemic calls for stricter drug regulation
Though the healthcare industry is slowly waking up to the hazards of opioid-based prescription drugs, their sale continues unabated across all markets,
Earnings preview: What to expect when Allergan reports Q1 2019 earnings results
Allergan plc (NYSE: AGN) is scheduled to report earnings results for the first quarter of 2019 on Tuesday, May 7, before market
Axsome Therapeutics stock climbs to 34-month high
After the slump on weak quarterly results, investors turned positive on Axsome Therapeutics (AXSM) stock, which climbed to the 34-month high of
DowDuPont’s stock tanks 5% after Q4 results miss estimates
DowDuPont Inc. (DWDP) missed market estimates on revenue and earnings for the fourth quarter of 2018, sending shares tumbling by 5.9% in
United Therapeutics, MannKind to co-develop pulmonary hypertension drug
The healthcare sector this week witnessed yet another instance of two companies coming together to find therapeutic solution for a challenging medical